Načítá se...
Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19)
Objective: to investigate the effectiveness of long-term oral administration of Actovegin in post-COVID patients with cognitive impairment (CI).Patients and methods. 444 patients (142 men, 302 women) with COVID-19 and CI participated in the study. One-half of the included participants – 222 patients...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2021-04-01
|
| Edice: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
| Témata: | |
| On-line přístup: | https://nnp.ima-press.net/nnp/article/view/1542 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|